Jason Wallenstein Honored by
BEDFORD, Mass., April 28 /PRNewswire-FirstCall/ -- Insulet Corporation employee, Jason Wallenstein, doesn't let his visual impairment or his diabetes keep him from sailing on a world-class level. Wallenstein and his SailBlind team members from the Carroll Center for the Blind in Newton, MA won the bronze medal in the B3 Division at the 2009 Blind Sailing World Championship Regatta in New Zealand. Wallenstein, who is 34, has Type 1 diabetes and is legally blind, served as the helmsman to steer a Noelex 25, a 25-foot sailboat to the third place victory.
Wallenstein and the SailBlind team were recognized today by both the Massachusetts Senate and the House of Representatives, led by Senator Cynthia Stone Creem and Representative Ruth B. Balser, both of Newton, MA. The SailBlind team was honored for their outstanding performance and ability to serve as an inspiration to other athletes with physical challenges.
"I have been sailing all my life. There was no reason why having Type 1 diabetes and becoming visually impaired later in life would hinder my desire to excel in the sport and compete," said Wallenstein. "I am truly honored to be recognized today by Senator Creem and Representative Balser. I hope that my experiences will demonstrate to others that life's challenges can be turned into opportunities."
Wallenstein works in the product customer service department of Insulet, the leader in tubing-free insulin pump technology with its OmniPod(R) Insulin Management System. "Thanks to the OmniPod, I was able to focus on competing, rather than my diabetes," continued Wallenstein. "As part of the OmniPod product support team, I know firsthand that it is durable enough to withstand the rigors of a world-class sailing competition."
"Jason exemplifies Insulet's mission to make diabetes a smaller part of life. We are inspired by his determination and proud that his accomplishments are being recognized by the Massachusetts State Legislature," said Duane DeSisto, President and Chief Executive Officer of Insulet Corporation.
About the OmniPod Insulin Management System
The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. The OmniPod System offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod -- a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager -- a wireless, menu-driven, hand-held device that programs the Pod.
About Insulet Corporation
Insulet Corporation (Nasdaq: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-requiring diabetes. Founded in 2000, Insulet is based in Bedford, MA.
Media Contacts: Erich Sandoval, Lazar Partners for Insulet Corporation Tel. +1-917-497-2867 E-mail: email@example.com
|SOURCE Insulet Corporation|
Copyright©2009 PR Newswire.
All rights reserved